Asthma

Follow
Illustration depicting RSV prevention injection in a newborn, shielding from virus and reducing future asthma risk, with healthy child growth.
Image generated by AI

RSV prevention in newborns could cut childhood asthma risk, study suggests

Reported by AI Image generated by AI Fact checked

Belgian researchers working with Danish partners report that respiratory syncytial virus (RSV) infections in early infancy are linked to a higher risk of childhood asthma, especially in children with a genetic tendency to allergies. In experimental models, protecting newborns from RSV prevented the immune changes associated with later asthma. The findings, published in Science Immunology, highlight potential long-term benefits of emerging RSV prevention tools.

Scientists at Case Western Reserve University have discovered that asthma may be driven by 'pseudo leukotrienes' formed through free-radical reactions, rather than the traditionally blamed leukotrienes produced by enzymes. These molecules appear at higher levels in asthma patients, correlating with symptom severity. The finding suggests potential new treatments targeting the root cause of inflammation.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline